What is the appropriate empiric management for an adult with a presumed bacterial skin infection, including first‑line oral antibiotic covering streptococci and methicillin‑sensitive Staphylococcus aureus (MSSA), criteria for adding methicillin‑resistant Staphylococcus aureus (MRSA) coverage, indications for incision and drainage, and when to admit for intravenous therapy?

Management of Bacterial Skin Infections in Adults

First-Line Oral Antibiotic for Typical Non-Purulent Cellulitis

For typical uncomplicated cellulitis without purulent drainage, prescribe cephalexin 500 mg orally every 6 hours or dicloxacillin 250–500 mg orally every 6 hours for exactly 5 days—MRSA coverage is unnecessary because beta-lactam monotherapy achieves 96% clinical success in these cases. 1

• Beta-lactam antibiotics (cephalexin, dicloxacillin, amoxicillin, or penicillin) are the standard of care because the primary pathogens are beta-hemolytic streptococci (especially Streptococcus pyogenes) and methicillin-sensitive Staphylococcus aureus (MSSA). 1, 2
• Treatment duration is 5 days if warmth, tenderness, and erythema are improving and the patient is afebrile; extend only if these signs persist. 1
• High-quality randomized controlled trial evidence confirms that 5-day courses are as effective as 10-day courses, with 98% clinical resolution at 14 days and no relapses by 28 days. 1

---

When to Add MRSA Coverage: Specific Risk Factors

Add MRSA-active antibiotics only when any of the following risk factors are present—do not add MRSA coverage reflexively for typical cellulitis, as this overtreats 96% of cases and promotes resistance. 1

Mandatory MRSA Coverage Triggers:

• Purulent drainage or exudate at the infection site (visible pus, weeping wound). 1, 3
• Penetrating trauma (e.g., puncture wound, laceration, animal bite) or injection drug use. 1
• Known MRSA colonization (nasal swab positive) or prior MRSA infection. 1
• Systemic inflammatory response syndrome (SIRS): fever >38°C, heart rate >90 bpm, respiratory rate >24 breaths/min, or altered mental status. 1
• Failure to respond to beta-lactam therapy after 48–72 hours. 1

MRSA-Active Oral Regimens (5 days, extend if no improvement):

• Clindamycin 300–450 mg orally every 6 hours provides single-agent coverage for both MRSA and streptococci, but use only if local MRSA clindamycin resistance is <10%. 1, 3
• Trimethoprim-sulfamethoxazole (TMP-SMX) 1–2 double-strength tablets twice daily PLUS a beta-lactam (cephalexin 500 mg four times daily or amoxicillin 500 mg three times daily) ensures dual MRSA and streptococcal coverage. 1, 3
• Doxycycline 100 mg orally twice daily PLUS a beta-lactam is an alternative combination; never use doxycycline alone because it lacks reliable streptococcal activity. 1

---

Incision and Drainage: Primary Treatment for Purulent Collections

Incision and drainage (I&D) is the definitive treatment for any drainable abscess, furuncle, or carbuncle—antibiotics are adjunctive and may be unnecessary in healthy patients with simple abscesses after adequate drainage. 3, 4

When Antibiotics Are Required After I&D:

• Systemic inflammatory response (fever, tachycardia, tachypnea, leukocytosis). 3
• Extensive surrounding cellulitis (erythema extending >5 cm from the abscess). 3
• Multiple infection sites or difficult-to-drain locations (face, hands, genitalia). 3
• Host factors: immunocompromise, diabetes, extremes of age, or lack of clinical improvement after drainage alone. 3

---

Indications for Intravenous Therapy and Hospitalization

Admit patients for IV antibiotics when any of the following are present—do not delay surgical consultation if necrotizing infection is suspected. 5, 1

Hospitalization Criteria:

• Systemic inflammatory response syndrome: fever, tachycardia, hypotension, or altered mental status. 1
• Signs of necrotizing infection: severe pain out of proportion to examination, skin anesthesia, rapid progression, "wooden-hard" subcutaneous tissue, gas in tissue, or bullous changes. 5, 1
• Severe immunocompromise or neutropenia. 1
• Failure of outpatient therapy after 24–48 hours. 1

IV Antibiotic Regimens:

For Uncomplicated Cellulitis Requiring Hospitalization (No MRSA Risk Factors):

• Cefazolin 1–2 g IV every 8 hours is the preferred IV beta-lactam. 1
• Nafcillin 2 g IV every 6 hours or oxacillin 2 g IV every 6 hours are alternatives. 5, 1

For Complicated Cellulitis with MRSA Risk Factors (A-I Evidence):

• Vancomycin 15–20 mg/kg IV every 8–12 hours (target trough 15–20 mg/L) is first-line. 1, 6
• Linezolid 600 mg IV twice daily, daptomycin 4 mg/kg IV once daily, or clindamycin 600 mg IV every 8 hours (if local resistance <10%) are equally effective alternatives. 1

For Severe Cellulitis with Systemic Toxicity or Suspected Necrotizing Fasciitis:

• Vancomycin 15–20 mg/kg IV every 8–12 hours PLUS piperacillin-tazobactam 3.375–4.5 g IV every 6 hours provides broad-spectrum coverage for polymicrobial, gram-negative, and anaerobic pathogens. 5, 1
• Alternative combinations: vancomycin plus a carbapenem (meropenem 1 g IV every 8 hours) or vancomycin plus ceftriaxone 2 g IV daily and metronidazole 500 mg IV every 8 hours. 5, 1
• Penicillin 2–4 million units IV every 4–6 hours PLUS clindamycin 600–900 mg IV every 8 hours is the specific regimen for documented group A streptococcal necrotizing fasciitis. 5

Treatment Duration:

• 5 days for uncomplicated cellulitis if clinical improvement occurs. 1
• 7–14 days for complicated infections, individualized based on clinical response. 1

---

Critical Pitfalls to Avoid

• Do not add MRSA coverage to every cellulitis case without specific risk factors—MRSA is uncommon in typical non-purulent cellulitis even in high-prevalence settings. 1
• Do not use doxycycline or TMP-SMX as monotherapy for typical cellulitis; they lack reliable activity against beta-hemolytic streptococci, the predominant pathogens. 1
• Do not prescribe antibiotics alone for drainable abscesses—incision and drainage is the cornerstone of therapy. 3
• Do not delay surgical consultation when signs of necrotizing infection (disproportionate pain, rapid progression, bullae, gas, or necrosis) are present; timely debridement is critical to prevent mortality. 5, 1
• Do not automatically extend therapy to 7–10 days based on residual erythema alone; extend only if warmth, tenderness, or erythema have not improved after 5 days. 1

---

Adjunctive Measures to Accelerate Healing and Prevent Recurrence

• Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage of edema and inflammatory substances. 1
• Examine interdigital toe spaces for tinea pedis, fissuring, scaling, or maceration; treat these conditions to eradicate colonization and reduce recurrent infection. 1
• Address predisposing conditions such as venous insufficiency, lymphedema, chronic edema, obesity, and eczema to lower recurrence risk. 1
• Consider prophylactic antibiotics (penicillin V 250 mg orally twice daily or erythromycin 250 mg twice daily) for patients with 3–4 episodes per year despite optimal management of risk factors. 1